Table 2. Clinical measures and outcomes of cancer patients with COVID-19.
| Variable | Total (%) | Alive (%) | Deceased (%) | p value |
|---|---|---|---|---|
| Hospital admission, n (%) | 73 (69.5) | 30 (28.5) | 43 (40.9) | 0.001 |
| Hospital length of stay, days | 17.9±12.9 | 14.7±11.7 | 20.1±13.3 | 0.03 |
| ICU admission, n (%) | 35 (33) | 4 (3.8) | 31 (29.5) | 0.001 |
| ICU length of stay, days | 4.7±6.8 | 0.5±2.2 | 8.4±7.4 | 0.001 |
| Mechanical ventilation, n (%) | 34 (32.3) | 2 (1.9) | 32 (30.4) | 0.001 |
| Disseminated intravascular coagulation, n (%) | 3 (2.86) | 0 | 3 (2.86) | 0.001 |
| Pneumonia, n (%) | 49 (46.6) | 14 (13.3) | 35 (33.3) | 0.001 |
| Renal replacement therapy, n (%) | 25 (23.8) | 3 (2.8) | 22 (20.9) | 0.001 |
| Septic shock, n (%) | 31 (29.5) | 1 (0.9) | 30 (28.5) | 0.001 |
Results expressed as absolute numbers and percent (%) or mean±standard deviation.
ICU: intensive care unit.